Zealand Pharma A/S
http://www.zealandpharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Zealand Pharma A/S
Device Classifications For COVID, Acute Febrile Illness IVDs And Force Separation Catheters
The FDA designated class II special controls classifications for two diagnostics and force separation catheters.
ProGen’s Dual Agonist Obesity Contender Gains Momentum With Rani Partnership
The CEO of South Korean biotech shares how his company was able to reach a partnership with Rani so quickly and why it is confident in its GLP-1/GLP-2 dual agonist for obesity and diabetes, despite recent disappointing clinical results for its sole rival.
Parexel Execs On Obesity, AI And Data Trends
Parexel’s chief strategy officer Kushal Gohil, clinical EVP Stephen Pyke and India head Sanjay Vyas share thoughts on possible hurdles to, and the cascading impact of obesity treatments, GenAI progress and the opportunities and challenges of real-world data in India.
Rare Diseases Rule, But Some Common Conditions Stand Out In Pending US Applications
Half of the FDA’s upcoming 2024 user fee goals target rare diseases, but highly prevalent conditions like uncomplicated urinary tract infections and atopic dermatitis are also up for agency action in the second half of the year.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Encycle Therapeutics, Inc.
- Valeritas Holdings, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice